Celiane Rey-Casserly1,2, Tanya Diver1,2. 1. Department of Psychiatry, Boston Children's Hospital. 2. Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
Abstract
PURPOSE OF REVIEW: Adverse late effects of pediatric brain tumors can be numerous and complex and potentially alter the life trajectories of survivors in a multitude of ways. We review these inter-related late effects that compromise neurocognitive function, general health, social and psychological adjustment, and overall adaptive and vocational outcomes, and threaten to undermine the ability of survivors to transition independently into adulthood and effectively manage their care. Intervention/prevention strategies and advances in treatment that may reduce such late effects are discussed. RECENT FINDINGS: Studies of neuropsychological late effects have revealed specific deficits in core cognitive functions of attention, working memory and processing speed, with many survivors demonstrating decline in working memory and processing speed over time, irrespective of tumor type or treatment. This in turn affects the ongoing development of higher order neurocognitive skills. Research also highlights the increasing burden of health-related, neuropsychological and psychosocial late effects into adulthood and impact across life outcomes. SUMMARY: Pediatric brain tumor survivors require coordinated interdisciplinary care, ongoing evaluation and management of late effects, and timely interventions focused on mitigating the impact of late effects. The transition to adulthood can be especially vulnerable and addressing barriers to care is of paramount importance.
PURPOSE OF REVIEW: Adverse late effects of pediatric brain tumors can be numerous and complex and potentially alter the life trajectories of survivors in a multitude of ways. We review these inter-related late effects that compromise neurocognitive function, general health, social and psychological adjustment, and overall adaptive and vocational outcomes, and threaten to undermine the ability of survivors to transition independently into adulthood and effectively manage their care. Intervention/prevention strategies and advances in treatment that may reduce such late effects are discussed. RECENT FINDINGS: Studies of neuropsychological late effects have revealed specific deficits in core cognitive functions of attention, working memory and processing speed, with many survivors demonstrating decline in working memory and processing speed over time, irrespective of tumor type or treatment. This in turn affects the ongoing development of higher order neurocognitive skills. Research also highlights the increasing burden of health-related, neuropsychological and psychosocial late effects into adulthood and impact across life outcomes. SUMMARY: Pediatric brain tumor survivors require coordinated interdisciplinary care, ongoing evaluation and management of late effects, and timely interventions focused on mitigating the impact of late effects. The transition to adulthood can be especially vulnerable and addressing barriers to care is of paramount importance.
Authors: Ineke M Olsthoorn; Alice Ann Holland; Raymond C Hawkins; Allen E Cornelius; Muhammad Usman Baig; Grace Yang; Daniel C Holland; Wafik Zaky; Peter L Stavinoha Journal: Front Neurosci Date: 2022-06-23 Impact factor: 5.152
Authors: Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata Journal: Pathol Oncol Res Date: 2020-07-13 Impact factor: 2.874
Authors: Diane Chen; John F Strang; Victoria D Kolbuck; Stephen M Rosenthal; Kim Wallen; Deborah P Waber; Laurence Steinberg; Cheryl L Sisk; Judith Ross; Tomas Paus; Sven C Mueller; Margaret M McCarthy; Paul E Micevych; Carol L Martin; Baudewijntje P C Kreukels; Lauren Kenworthy; Megan M Herting; Agneta Herlitz; Ira R J Hebold Haraldsen; Ronald Dahl; Eveline A Crone; Gordon J Chelune; Sarah M Burke; Sheri A Berenbaum; Adriene M Beltz; Julie Bakker; Lise Eliot; Eric Vilain; Gregory L Wallace; Eric E Nelson; Robert Garofalo Journal: Transgend Health Date: 2020-12-11
Authors: Jan Stubberud; Ruth Hypher; Anne E Brandt; Torun G Finnanger; Eva Skovlund; Stein Andersson; Kari Risnes; Torstein B Rø Journal: Front Neurol Date: 2022-04-14 Impact factor: 4.086
Authors: Jason Fangusaro; Duane A Mitchell; Mehmet Kocak; Giles W Robinson; Patricia Ann Baxter; Eugene I Hwang; Jianping Huang; Arzu Onar-Thomas; Ira J Dunkel; Maryam Fouladi; Katherine E Warren Journal: Pediatr Blood Cancer Date: 2020-10-07 Impact factor: 3.167